The biology of the receptor for advanced glycation end products and its ligands

This publication has 37 references indexed in Scilit:

• Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways
  Journal of Biological Chemistry, 1999
• RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin Polypeptides
  Published by Elsevier ,1999
• Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.
  Journal of Clinical Investigation, 1998
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
  Nature, 1996
• Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
  Journal of Clinical Investigation, 1996
• Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
  Journal of Clinical Investigation, 1995
• N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins
  Biochemistry, 1995
• Free radicals and disruption of neuronal ion homeostasis in AD: A role for amyloid β-peptide?
  Neurobiology of Aging, 1995
• Lipoprotein and receptor interactions in vivo
  Current Opinion in Lipidology, 1995
• beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
  Journal of Clinical Investigation, 1993